{"product_id":"recombinant-severe-acute-respiratory-syndrome-coronavirus-2-spike-glycoprotein-s-partial-active-bhp10509257","title":"Recombinant Severe acute respiratory syndrome coronavirus 2 Spike glycoprotein (S), partial (Active)","description":"\u003ch2\u003eOverview\u003c\/h2\u003e \u003cp\u003eRecombinant Severe acute respiratory syndrome coronavirus 2 Spike glycoprotein (S), partial (Active) is a recombinant protein reagent derived from Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) and produced in Mammalian cell. It is commonly used to support Microbiology research by enabling binding assays, assay development and protein–protein interaction studies in controlled in vitro settings.\u003c\/p\u003e \u003ch2\u003eKey elements and design rationale\u003c\/h2\u003e\u003cul\u003e \u003cli\u003e\n\u003cstrong\u003eExpressed region:\u003c\/strong\u003e 16-685aa. Region selection can focus on functional domains, improve solubility, or isolate interaction surfaces for targeted studies.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eExpression system:\u003c\/strong\u003e Mammalian cell. Expression host can influence folding and the presence\/absence of post-translational modifications.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eTag \/ fusion:\u003c\/strong\u003e N-terminal 10xHis-tagged and C-terminal Flag-tagged. Tags can support purification and detection; evaluate potential tag effects when studying sensitive interactions.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eMolecular weight (reported):\u003c\/strong\u003e 79.6 kDa. Apparent size may vary with tags, processing, and gel conditions.\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eWhen comparing results across batches or platforms, interpret signals in the context of construct design (region, tags) and expression host, especially for modification-dependent interactions.\u003c\/p\u003e \u003ch2\u003eBiological background\u003c\/h2\u003e \u003cp\u003eThe gene commonly associated with this target is \u003cstrong\u003eS\u003c\/strong\u003e. SARS2-S-P refers to a protein target that is studied across multiple biological contexts; annotations and nomenclature can vary by species and isoform. This product corresponds to the Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) sequence context, which can be important when comparing homologs or orthologs across model systems. For curated functional annotations, domains, and sequence features, consult primary databases (e.g., UniProt\/NCBI) and the recent literature for the specific organism and isoform.\u003c\/p\u003e \u003ch2\u003eResearch relevance and current trends\u003c\/h2\u003e\u003cul\u003e \u003cli\u003eUsing recombinant proteins to enable quantitative binding measurements and reagent benchmarking.\u003c\/li\u003e \u003cli\u003eStudying domain- and isoform-specific effects in pathway models and interaction networks.\u003c\/li\u003e \u003cli\u003eDeveloping robust, reproducible assays that connect molecular readouts to cellular phenotypes.\u003c\/li\u003e \u003c\/ul\u003e \u003ch2\u003eCommon research applications\u003c\/h2\u003e\u003cul\u003e \u003cli\u003eAssay and standard development for immunoassays or binding-based detection methods.\u003c\/li\u003e \u003cli\u003eProtein–protein interaction studies (e.g., receptor–ligand or complex assembly) using purified components.\u003c\/li\u003e \u003cli\u003eStructure–function analysis, including domain mapping or evaluation of sequence variants.\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eIn quantitative assay development, changes in binding or activity readouts are typically interpreted relative to appropriate negative\/positive controls and, where possible, orthogonal assay formats that support the same conclusion.\u003c\/p\u003e \u003ch2\u003eNotes for experimental interpretation\u003c\/h2\u003e\u003cul\u003e \u003cli\u003eRecombinant constructs may represent a defined region (domain) rather than the full-length protein; interpret results in the context of the expressed region.\u003c\/li\u003e \u003cli\u003eTag or fusion elements can aid purification and detection but may influence binding surfaces or oligomerization; consider tag controls when relevant.\u003c\/li\u003e \u003cli\u003eSpecies and isoform differences can affect interaction partners and post-translational modifications; align experimental controls to the intended biological context.\u003c\/li\u003e \u003c\/ul\u003e \u003c!-- Sources (internal): - UniProtKB entry for P0DTC2 — UniProt — https:\/\/www.uniprot.org\/uniprotkb\/P0DTC2\/entry - NCBI Gene search (S) — NCBI — https:\/\/www.ncbi.nlm.nih.gov\/gene\/?term=S - PubMed search (S) — NCBI — https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=S - RCSB PDB search (S) — RCSB PDB — https:\/\/www.rcsb.org\/search?query=S - PubMed search (SARS2-S-P) — NCBI — https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=SARS2-S-P --\u003e","brand":"CUSABIO TECHNOLOGY LLC","offers":[{"title":"1 mg","offer_id":53065282093421,"sku":"CSB-MP3324GMY-1MG","price":3168.0,"currency_code":"USD","in_stock":true},{"title":"100 ug","offer_id":53065417589101,"sku":"CSB-MP3324GMY-100UG","price":448.0,"currency_code":"USD","in_stock":true},{"title":"20 ug","offer_id":53065417621869,"sku":"CSB-MP3324GMY-20UG","price":256.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/CSB-MP3324GMY-SDS.jpg?v=1772476433","url":"https:\/\/www.ebiohippo.com\/products\/recombinant-severe-acute-respiratory-syndrome-coronavirus-2-spike-glycoprotein-s-partial-active-bhp10509257","provider":"BioHippo","version":"1.0","type":"link"}